DIMENSIONAL FUND ADVISORS LP

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 354204 AUSTIN, TX

Position in ABOS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$778,461

+$495,839 QoQ

Shares Held

291,559

+143.5% QoQ

Ownership

0.403%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 96 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 73% Shared 22% None 6%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ABOS ranks #167 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$778,461	291,559	+143.5%	Shares	Sole	2026-08-11
2026-03-31	$282,622	119,756	+144.1%	Shares	Sole	2026-05-07
2025-12-31	$103,520	49,062	+12.7%	Shares	Sole	2026-02-12
2025-09-30	$74,425	43,524	0.0%	Shares	Sole	2025-11-12
2025-06-30	$50,487	43,524	0.0%	Shares	Sole	2025-08-12
2025-03-31	$47,876	43,524	-55.6%	Shares	Sole	2025-05-13
2024-12-31	$168,586	98,016	+73.3%	Shares	Sole	2025-02-13
2024-09-30	$140,257	56,556	+0.0%	Shares	Sole	2024-11-07
2024-06-30	$136,845	56,548	-8.4%	Shares	Sole	2024-08-09
2024-03-31	$249,997	61,728	+10.6%	Shares	Sole	2024-05-10
2023-12-31	$214,236	55,791	-26.2%	Shares	Sole	2024-02-07
2023-09-30	$313,747	75,602	+9.6%	Shares	Sole	2023-11-09
2023-06-30	$331,788	68,979	+3.3%	Shares	Sole	2023-08-09
2023-03-31	$271,121	66,779	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.